These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1551275)

  • 41. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Idiotypic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg).
    Kaveri SV; Dietrich G; Jobin D; Rossi F; Sultan Y; Lockwood CM; Kazatchkine MD
    Adv Nephrol Necker Hosp; 1992; 21():329-46. PubMed ID: 1566650
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of chronic hepatitis.
    Schaffner F
    Semin Liver Dis; 1985 Aug; 5(3):209-20. PubMed ID: 3931228
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chronic active hepatitis: recurrence after long-term immunosuppressive therapy in spite of normal liver histology].
    Manns M; Meyer zum Büschenfelde KH; Dienes HP; Dormeyer HH
    Z Gastroenterol; 1983 Dec; 21(12):700-8. PubMed ID: 6666186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.
    Nouri-Aria KT; Hegarty JE; Alexander GJ; Eddleston AL; Williams R
    Clin Exp Immunol; 1985 Aug; 61(2):290-6. PubMed ID: 3876182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meningitis and hepatitis complicating intravenous immunoglobulin therapy.
    Shorr AF; Kester KE
    Ann Pharmacother; 1996 Oct; 30(10):1115-6. PubMed ID: 8893119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
    Lehmann HC; Hartung HP
    J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigliadin antibody classes in chronic liver disease.
    Floreani A; Chiaramonte M; Venturini R; Plebani M; Martin A; Giacomini A; Naccarato R
    Ital J Gastroenterol; 1992 Oct; 24(8):457-60. PubMed ID: 1421449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
    Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intravenous immunoglobulin therapy is more and more common. The increasing tempo can force a prioritization of patients, scientists are warning].
    Orn P
    Lakartidningen; 1999 May; 96(18):2186-9. PubMed ID: 10377651
    [No Abstract]   [Full Text] [Related]  

  • 53. Intravenous immunoglobulin: striving for appropriate use.
    Kumar A; Teuber SS; Gershwin ME
    Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The therapeutic effect of intravenous immunoglobulins and vitamin C on the progression of experimental autoimmune myocarditis in the mouse.
    Gong F; Hu Y; Chen L; Gu W
    Med Sci Monit; 2007 Nov; 13(11):BR240-246. PubMed ID: 17968290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunotherapy of high dose intravenous immunoglobulins: basic mechanisms of action and clinical implications].
    Korsak J; Kłos M
    Pol Arch Med Wewn; 2001 Nov; 106(5):1071-7. PubMed ID: 12026522
    [No Abstract]   [Full Text] [Related]  

  • 56. Mechanism of intravenous immune globulin therapy.
    Spellberg B
    N Engl J Med; 1999 Jul; 341(1):57-8. PubMed ID: 10391765
    [No Abstract]   [Full Text] [Related]  

  • 57. Safety of intravenous immunoglobulin for treatment of auto-immune thrombocytopenia.
    Gutteridge CN; Veys P; Newland AC
    Acta Haematol; 1988; 79(2):88-90. PubMed ID: 3124479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meeting report: International Autoimmune Hepatitis Group.
    Johnson PJ; McFarlane IG
    Hepatology; 1993 Oct; 18(4):998-1005. PubMed ID: 8406375
    [No Abstract]   [Full Text] [Related]  

  • 59. Hazards of interferon treatment in patients with autoimmune chronic active hepatitis.
    Farhat BA; Johnson PJ; Williams R
    J Hepatol; 1994 Apr; 20(4):560-1. PubMed ID: 7519636
    [No Abstract]   [Full Text] [Related]  

  • 60. Alteration of the lung parenchyma associated with autoimmune hepatitis.
    Kayser K; Paul K; Feist D; Hofmann W; Wille L; Gabius HJ
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):153-7. PubMed ID: 1871959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.